Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: United Kingdom Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20081
20094
20102
20112
20123
20135
20142
20154
20161
20174
20186
20195
20214
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer8
Bristol-Myers Squibb3
Eisai Inc.3
Hoffmann-La Roche3
Imperial College London3
BeiGene2
Exelixis2
Merck Sharp & Dohme LLC2
Pfizer2
University of Oxford2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular49
Liver Neoplasms12
Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms4
Breast Neoplasms2
Carcinoma, Renal Cell2
Cholangiocarcinoma2
Fibrosis2
Glioblastoma2

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.